Immunome Inc. — Investor Relations & Filings
Immunome Inc. is a clinical-stage oncology company focused on developing targeted therapies to improve outcomes for cancer patients. The company specializes in creating first-in-class and best-in-class therapeutic candidates, with a primary focus on Antibody-Drug Conjugates (ADCs) and Radioligand Therapies (RLTs). Immunome utilizes a systematic, data-driven process to optimize each component of its drug candidates—antibody, linker, and payload—to address high unmet medical needs. Its clinical pipeline includes varegacestat, a gamma secretase inhibitor in a Phase 3 trial for desmoid tumors; IM-1021, a ROR1-targeted ADC in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand. The company also advances a portfolio of preclinical ADCs targeting various solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | |
| 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | |
| 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | |
| 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | |
| 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 36260617 | ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | ||
| 33050365 | SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | ||
| 33017259 | 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | ||
| 33000829 | 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | ||
| 32892309 | 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 32892308 | 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 29982218 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
8 filings
| |||||
| 12302604 | Director's Dealing 2025 | 2025-12-31 | English | ||
| 12302605 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12302609 | Major Shareholding Notification 2025 | 2025-12-23 | English | ||
| 12302606 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302607 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302608 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302610 | Director's Dealing 2025 | 2025-12-18 | English | ||
| 12302611 | 8-K | 2025-12-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
Immunome Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32238/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32238 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32238 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32238 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32238}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immunome Inc. (id: 32238)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.